Oxazepam is mutagenic in vivo in Big Blue transgenic mice.

Although oxazepam (Serax), a widely used benzodiazepine anxiolytic, does not induce gene mutations in vitro or chromosomal aberrations in vivo, it was found to be a hepatocarcinogen in a 2 year bioassay in B6C3F1 mice. Thus, it was of interest to determine whether this carcinogen is mutagenic in vivo. Male B6C3F1 Big Blue transgenic mice were fed 2500 p.p.m. oxazepam or control diet alone for 180 days and killed on the next day. The mutant frequency (MF) of lacI in control mice was 5.02 +/- 2.4x10(5), whereas the MF in the oxazepam-treated mice was 9.17 +/- 4.82x10(-5), a significant increase (P < 0.05). Correction of the mutant frequency of lacI from the oxazepam-treated mice for clonality resulted in a decrease in the mean mutant frequency to 8.15 +/- 2. 54x10(-5). Although the mutant frequency difference was small, sequencing of a random collection of the mutants from each oxazepam-exposed mouse showed a significant difference (P < 0.015) in the mutation spectrum compared with that from control mice. In the oxazepam-exposed mice, an increase in G:C-->T:A and G:C-->C:G transversions and a concomitant decrease in G:C-->A:T transitions were observed. Clonal expansion of mutations at guanines in 5'-CpG-3' sequencing contexts at three sites was noted. It is postulated that some of the mutations found in the oxazepam-derived spectrum were due to oxidative damage elicited by induction of CYP2B isozymes as the result of chronic oxazepam administration. This study demonstrates that the in vivo Big Blue transgenic rodent mutation assay can detect mutations derived from a carcinogen that did not induce gene mutations in vitro or micronuclei in mouse bone marrow. Moreover, the sequencing of the recovered mutants can distinguish between the mutation spectrum from treated mice compared with that from control mice, thereby confirming the genotoxic consequences.

[1]  S. Cohen.  Cell Proliferation and Carcinogenesis , 1998 .

[2]  K. Kolaja,et al.  The role of oxidative stress in chemical carcinogenesis. , 1998, Environmental health perspectives.

[3]  K. Tindall,et al.  Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy. , 1997, Mutation research.

[4]  M. Cunningham,et al.  Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens. , 1996, Mutation research.

[5]  S. Banerjee,et al.  Genetic toxicology of four commonly used benzodiazepines: a review. , 1996, Mutation research.

[6]  H. Matthews,et al.  Cell proliferation as a determining factor for the carcinogenicity of chemicals: studies with mutagenic carcinogens and mutagenic noncarcinogens. , 1995, Toxicology letters.

[7]  M. Cunningham,et al.  Activity of hepatic drug metabolizing enzymes following oxazepam-dosed feed treatment in B6C3F1 mice. , 1995, Toxicology letters.

[8]  D. Parke,et al.  The cytochromes P450 and mechanisms of chemical carcinogenesis. , 1994, Environmental health perspectives.

[9]  J. Haseman,et al.  Carcinogenicity studies of oxazepam in mice. , 1994, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[10]  R. Eritja,et al.  Nucleotide Insertion and Primer Extension at Abasic Template Sites in Different Sequence Contexts a , 1994, Annals of the New York Academy of Sciences.

[11]  J. Bucher,et al.  Low frequency of H-ras mutations in hepatocellular adenomas and carcinomas and in hepatoblastomas from B6C3F1 mice exposed to oxazepam in the diet. , 1994, Carcinogenesis.

[12]  L. Loeb,et al.  Reactive oxygen species in tumorigenesis. , 1994, Cancer research.

[13]  C. Mathews,et al.  Effect of DNA cytosine methylation upon deamination-induced mutagenesis in a natural target sequence in duplex DNA. , 1994, Journal of Biological Chemistry.

[14]  J. A. Bond,et al.  Molecular analysis of lacI mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene. , 1994, Carcinogenesis.

[15]  H. Maki,et al.  Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA synthesis. , 1993, The Journal of biological chemistry.

[16]  C. Körber,et al.  An investigation of micronucleus and mutation induction by oxazepam in mammalian cells. , 1993, Mutagenesis.

[17]  J. T. Macgregor,et al.  Induction of hepatic mutations in lacI transgenic mice. , 1993, Mutagenesis.

[18]  C. Menck,et al.  Singlet oxygen induced mutation spectrum in mammalian cells. , 1992, Nucleic acids research.

[19]  J. Miller,et al.  Evidence that MutY and MutM combine to prevent mutations by an oxidatively damaged form of guanine in DNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. Ellwein,et al.  Genetic errors, cell proliferation, and carcinogenesis. , 1991, Cancer research.

[21]  Barry Halliwell,et al.  DNA damage by oxygen‐derived species Its mechanism and measurement in mammalian systems , 1991, FEBS letters.

[22]  L. Loeb,et al.  Mutagenic spectrum resulting from DNA damage by oxygen radicals. , 1991, Biochemistry.

[23]  B. Ames,et al.  Chemical carcinogenesis: too many rodent carcinogens. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Adams Wt,et al.  Statistical test for the comparison of samples from mutational spectra , 1987 .

[25]  Jeffrey H. Miller,et al.  Mutagenic deamination of cytosine residues in DNA , 1980, Nature.

[26]  Fox Ka,et al.  Liver-cell adenomas and peliosis hepatis in mice associated with oxazepam. , 1974 .

[27]  K. Tindall,et al.  Spectrum of spontaneous mutations in liver tissue of lacI transgenic mice , 1997, Environmental and molecular mutagenesis.

[28]  B. Glickman,et al.  An efficient laboratory protocol for the sequencing of large numbers of lacI mutants recovered from Big Blue transgenic animals. , 1996, Environmental and molecular mutagenesis.

[29]  K. Tindall,et al.  Spectrum of mutations in kidney, stomach, and liver from lacI transgenic mice recovered after treatment with tris(2,3-dibromopropyl)phosphate. , 1996, Environmental and molecular mutagenesis.

[30]  K. Tindall,et al.  Mutational specificity: Spectrum of mutations in kidney, stomach, and liver from lacl transgenic mice recovered after treatment with tris(2,3‐dibromopropyl)phosphate , 1996 .

[31]  B. Glickman,et al.  Mutational specificity: An efficient laboratory protocol for the sequencing of large numbers of lacl mutants recovered from Big Blue® transgenic animals , 1996 .

[32]  T. K. Baker,et al.  Modulation of gap junctional intercellular communication in rodent, monkey and human hepatocyte by nongenotoxic compounds. , 1995, Progress in clinical and biological research.

[33]  J. Bucher,et al.  Early responses of the liver of B6C3F1 mice to the hepatocarcinogen oxazepam. , 1994, Toxicology and applied pharmacology.

[34]  C. Ioannides,et al.  Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis. , 1993, Drug metabolism reviews.

[35]  J. Short,et al.  Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacl shuttle vector , 1991, Environmental and molecular mutagenesis.

[36]  G. Brambilla,et al.  Absence of liver DNA fragmentation in rats treated with high oral doses of 32 benzodiazepine drugs. , 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[37]  T. Shepard,et al.  National toxicology program. , 1981, Teratology.